Section 5 Treatment and health service provision

Size: px
Start display at page:

Download "Section 5 Treatment and health service provision"

Transcription

1 Section Section Treatment and health service provision Chronic Kidney Disease 0 Australian PEEK Study

2 Section Section : Experience of treatment Summary Treatments experienced The most commonly used treatment reported were ACE inhibitors (n=;.%), followed by vitamin D (n=;.%), statins (n=0,.%) and hospital based haemodialysis (n=;.%). The least reported were Continuous Ambulatory Peritoneal Dialysis (CAPD) (n=;.00%) and home-based haemodialysis (n=;.%). Quality of life while using treatments As a follow-up question (within the questionnaire), participants were asked to rate their quality of life on a scale of to, while using each specific treatment (with being Life was very distressing and being Life was great ). All forms of dialysis rated the poorest in relation to quality of life while the treatments that had the least impact on quality of life were ACE inhibitors (mean score.0), vitamin D (mean score.), statins (mean score.0) and beat blockers (mean score.0). Effectiveness of treatments A second follow-up question was asked in relation to how effective the participant felt the treatment was on a scale of to (with being ineffective and being very effective. Three therapies scored an average of.00 in relation to effectiveness including EPO, hospital based haemodialysis and home based haemodialysis. The remaining therapies all scored between.00 and., with the exception of Automated Peritoneal Dialysis which scored an average of.00. Side effects of treatments In relation to side-effects that participants could cope with, there were very few trends within this question as when asked, participants often went straight into discussing the difficult side effects, nevertheless, close to half of the participants (n=0;.%) described being able to cope with all side effects, however this was often followed with a note suggesting that they had no choice but to cope. The main theme in relation to difficult side effects was the psychological stress (n=;.%), noting the relentless nature of the disease (i.e. it is always there). Other side effects that were difficult to cope with were weakness/fatigue (n=;.%) and weight gain and bloating (n=;.%). There were a number of sub-group variations. Participants with stage / disease reported difficulty coping with weakness and fatigue less frequently while participants with stage disease reported this more frequently than the general cohort (.% stage / disease,.00% stage and.% for the general cohort). Stage / disease participants reported difficulties with weight gain/bloating more frequently than the general cohort (.% stage / disease compared to.% in the general cohort). Participants with hyperkalaemia reported difficulties with weight gain/bloating less frequently than the general cohort (.% compared to.% in the general cohort). Changes in medications Participants were asked whether they had ever needed to change medications. The main changes in medication noted were in relation to cardiovascular therapies, particularly blood pressure medications (n=;.%). There were participants (.%) that described a single change in medication for across a range of conditions and (.%) that had not had a change in medication. There were also seven participants (.00%) that described multiple changes in medications. There was one variation in relation to sub-groups. Participants with stage disease reported changes in medication in relation to cardiovascular therapies less frequently than the general cohort (.00% compared to.% in the general cohort). Participants were asked whether their doctor had provided a clear explanation for the reason for any changes in medication. The majority of participants (n=;.%) described changes in medication being explained and being satisfied with the explanation. were also eight participants (.%) that described a change in medication being made at their request, often after conducting research of their own. Chronic Kidney Disease 0 Australian PEEK Study

3 Section Adherence to medications Participants were asked how long they stick with a therapy before they think it might not be working or give up on it. (.%) participants stated that they stick with medications as long as it is prescribed, often noting their trust in their treating clinician. There were ten participants (.%) that stated they adhere to medications as long as they feel they are working, and some participants relied on their regular check-ups and blood tests to determine this. An additional ten participants (.%) said that they maintain the therapy for two to three months to see if it is working and a further ten participants (.%) noted that they use the treatment as long as tolerated, without detriment to their health otherwise. There were a number of sub-group variations. Regional/rural participants reported adhering to medications for - months (.% compared to.0% for metropolitan participants) or as long as tolerated more frequently than metropolitan participants (.% compared to.% for metropolitan participants). There were also no participants with hyperkalaemia that reported adhering to medications for - months. Participants were asked what needed to change for them to feel as though a treatment is working. The most common response was the need to see improvements in clinical tests, particularly blood tests (n=;.%), followed by generally feeling better and being able to do everyday tasks (n=0;.%). Use of complementary therapies Participants were asked whether they had used any complementary therapies. Where complementary therapies were used, these were primarily vitamins and supplements (n=;.%)and massage (including physiotherapy) (n=;.%). Almost half of the participants (n=;.%) stated that they did not use complementary therapies, with many noting that they would not do so without the permission of their treating clinician. There were a number of sub-group variations. Participants with stage disease reported not using complementary therapies less frequently than the general cohort (0.00% compared to.% in the general cohort). They also described accessing massage or physiotherapy more frequently (0.00% compared to.% in the general cohort), while participants with stage / disease reported this less frequently (.% compared to.% in the general cohort). Participants with stage disease also reported diet and lifestyle changes more frequently than the general cohort (0.00% compared to.00% in the general cohort). Service provision and affordability The majority of participants were treated for CKD in the public healthcare system (n=, 0.00%), as a public patient (n=,.%), and had health insurance (n=,.%). The majority of patients never had to cancel healthcare appointments (n=, 0.00%), and they were never unable to afford essential prescriptions (n=,.%). However, over a third of participants (n=,.%) sometimes or often were unable to pay for basic necessities such as housing, food and electricity. Other costs to participants include the need for a carer (n=,.%) and changes in employment status resulting in lost income (n=,.%). Chronic Kidney Disease 0 Australian PEEK Study

4 Treatments experienced Section Participants were asked in the questionnaire to identify the treatments that they had experienced (excluding surgery). The most commonly used treatment reported were ACE inhibitors (n=;.%), followed by vitamin D (n=;.%), statins (n=0;.%) and hospital based haemodialysis (n=;.%). The least reported were Continuous Ambulatory Peritoneal Dialysis (CAPD) (n=;.00%) and home-based haemodialysis (n=;.%). Table.: Treatments experienced Treatments experienced (n=) by stage of disease Stage / n= ACE inhibitors.% Vitamin D.% Statins.0% Hospital or center based haemodialysis.% Angiotensin II receptor blockers (ARBs).% Diuretics.% Beta blockers.% Phosphate binders.0% Calcium channel blockers.0% EPO.% Automated Peritoneal Dialysis (APD).% Home based haemodialysis.% Continuous Ambulatory Peritoneal Dialysis (CAPD).% Stage n=0 0.00% 0.00%.00%.00%.00% 0.00% 0.00%.00% 0.00% 0.00%.00%.00%.00% Stage / n= 0.%.%.%.%.%.% 0.%.%.%.0% 0.%.%.% n=0.%.% 0.%.%.%.% 0.00% 0.%.% 0.00% 0.00%.%.00% Treatments experienced (n=) comparison with comorbidities Anxiety n= Hyperkalaemia n=0 Hypertension n= Sleep problems n= n=0 ACE inhibitors.% Vitamin D.% Statins.% Hospital or center based haemodialysis.% Angiotensin II receptor blockers (ARBs).% Diuretics.% Beta blockers.% Phosphate binders.% Calcium channel blockers.0% EPO.% Automated Peritoneal Dialysis (APD).% Home based haemodialysis.% Continuous Ambulatory Peritoneal Dialysis (CAPD).%.%.%.%.%.%.%.%.%.%.%.% 0.00%.%.%.%.%.%.0%.%.0%.0%.%.%.%.%.%.%.% 0.00%.%.%.%.%.%.%.0%.%.%.%.%.% 0.%.%.%.% 0.00% 0.%.% 0.00% 0.00%.%.00% Chronic Kidney Disease 0 Australian PEEK Study

5 Section As a follow-up question (within the questionnaire), participants were asked to rate their quality of life on a scale of to, while using each specific treatment (with being Life was very distressing and being Life was great ). All forms of dialysis rated the poorest in relation to quality of life (see table.) while the treatments that had the least impact on quality of life were ACE inhibitors (mean score.0), vitamin D (mean score.), statins (mean score.0) and beat blockers (mean score.0). Table.: Quality of life while using treatments Treatment (n=) n= Mean QoL Life was very score distressing (Score = ) Life was distressing (Score = ) Life was a little distressing (Score = ) Life was average (Score = ) Life was good (Score = ) Life was very good Life was great (Score = ) (Score = ) n= % n= % n= % n= % n= % n= % n= % ACE inhibitors Vitamin D Statins Beta blockers Angiotensin II receptor blockers (ARBs) Calcium channel blockers EPO Phosphate binders Diuretics Hospital or center based haemodialysis Home based haemodialysis Continuous Ambulatory Peritoneal Dialysis (CAPD) Automated Peritoneal Dialysis (APD) Chronic Kidney Disease 0 Australian PEEK Study

6 Section Figure.: Mean quality of life scores in relation to treatments A second follow-up question was asked in relation to how effective the participant felt the treatment was on a scale of to (with being ineffective and being very effective. Three therapies scored an average of.00 in relation to effectiveness including EPO, hospital based haemodialysis and home based haemodialysis. The remaining therapies all scored between.00 and., with the exception of Automated Peritoneal Dialysis which scored an average of.00. Table.: Effectiveness of treatments Treatment (n=) n= Mean Effectiveness score Ineffective Score = Somewhat effective Score = Moderately effective Score = Effective Score = Very effective Score = n= % n= % n= % n= % n= % EPO Hospital or center based haemodialysis Home based haemodialysis Diuretics Angiotensin II receptor blockers (ARBs) Vitamin D Calcium channel blockers Phosphate binders Beta blockers ACE inhibitors Statins Continuous Ambulatory Peritoneal Dialysis (CAPD) Automated Peritoneal Dialysis (APD) Chronic Kidney Disease 0 Australian PEEK Study

7 Section 0 EPO Hospital or Home based center based haemodialysis haemodialysis Diuretics Angiotensin II receptor blockers (ARBs) Vitamin D Calcium channel blockers Figure.: Mean effectiveness scores in relation to treatments Phosphate binders Beta blockers ACE inhibitors Statins Continuous Ambulatory Peritoneal Dialysis (CAPD) Automated Peritoneal Dialysis (APD) Side effects of treatment Participants were guided to reflect on the side effects that they had experienced from their various treatments. They were then asked two, separate questions in relation to the side effects that they felt they could cope with, and the side effects that were very difficult to cope with. There were very few trends within this question as when asked, participants often went straight into discussing the difficult side effects, nevertheless, close to half of the participants (n=0;.%) described being able to cope with all side effects, however this was often followed with a note suggesting that they had no choice but to cope. There was one sub-group variation. Participants with stage / disease described being able to cope will all side effects/not having a choice more frequently than participants with stage / or stage disease (.% compared with.0% stage / and 0.00% stage disease) I suppose you've got to cope with everything don't you, you do what you're told or you die. [Participant ] I've been able to cope with most of it. I mean, I haven't really got much choice. [Participant 0] None of them really. Because it's just... I've managed them, that's probably about as good as it gets. [Participant ] Chronic Kidney Disease 0 Australian PEEK Study

8 Section Table.: Side effects that participants could cope with Participant describes being able to cope with (n=) by stage of disease Stage / n= Stage n=0 Stage / n= n=0 All of the side effects/not much choice but to cope.0% 0.00%.% 0.% Weight gain and bloating.0%.00%.%.% Participant describes being able to cope with (n=) comparison with comorbidities Anxiety n= Hyperkalaemia n=0 Hypertension n= Sleep problems n= n=0 All of the side effects/not much choice but to cope.% 0.00%.%.% 0.% Weight gain and bloating.%.%.%.%.% Participant describes being able to cope with (n=) comparison with location Regional/Rural n= Metropolitan n= n=0 All of the side effects/not much choice but to cope.% Weight gain and bloating.%.%.% 0.%.% Weight gain and bloating All of the side effects/not much choice but to cope Figure.: Side effects that participants could cope with (% of all participants) As noted, participants in this study had stronger opinions about the side effects that they found difficult (compared with those that they could cope with). The main theme in relation to difficult side effects was the psychological stress (n=;.%), noting the relentless nature of the disease (i.e. it is always there): Psychological distress we found very hard, very hard indeed. As far as the hemodialysis, I can handle that quite well because the social part of it is quite good. Needs a bit of improvement, different personalities et cetera, et cetera, in the unit. There was a lot of tears and sobbing, et cetera, et cetera. I can't handle this anymore sort of statements. Then you go see Professor NAME and cry on his shoulder more or less. [Participant ] I guess. Just that constant fear of not going backwards and not... and that constant worry of, you know... of that thought of losing that... the kidney function that I have. I guess that's probably really the only... is the only negative, I'd say. Is just that constant worry. You know, I don't want to end up on dialysis so... yeah. [Participant ] I think it was the mental side effects, the mental like... There's something wrong, what is wrong? Where is this coming from? So, it was all that. It was the unknowing, that side effect...well, all of them, but your mind gets sort around it if you've got pain hours a day. [Participant ] Chronic Kidney Disease 0 Australian PEEK Study

9 Section Other side effects that were difficult to cope with were weakness/fatigue (n=;.%) and weight gain and bloating (n=;.%). There were no significant variation between male and female responses and other demographic variables. There were a number of sub-group variations. Participants with stage / disease reported difficulty coping with weakness and fatigue less frequently while participants with stage disease reported this more frequently than the general cohort (.% stage / disease,.00% stage and.% for stage /). Stage / disease participants reported difficulties with weight gain/bloating more frequently than the general cohort (.% stage / disease compared to.% in the general cohort). Participants with hyperkalaemia reported difficulties with weight gain/bloating less frequently than the general cohort (.% compared to.% in the general cohort). Table.: Side effects that participants found difficult to cope with Participant describes difficult side effects (n=) by stage of disease Stage / n= Stage n=0 Stage / n= n=0 Psychological distress, anger and relentless nature of kidney disease (always there).% Weakness/Fatigue/Insomnia.% Weight gain/bloating.% None very difficult.% 0.00%.00%.00%.00%.%.%.%.%.%.%.%.% Participant describes difficult side effects (n=) comparison with comorbidities Anxiety n= Hyperkalaemia n=0 Hyperension n= Sleep problems n= n=0 Psychological distress, anger and relentless nature of kidney disease (always there).%.%.0%.0%.% Weakness/Fatigue/Insomnia Weight gain/bloating.%.%.%.%.%.%.%.%.%.% None very difficult.%.%.%.%.% Participant describes difficult side effects (n=) comparison with location Regional/Rural n= Metropolitan n= n=0 Psychological distress, anger and relentless nature of kidney disease (always there) Weakness/Fatigue/Insomnia Weight gain/bloating.%.%.% None very difficult.%.0%.0%.%.0%.%.%.%.% 0 0 Psychological distress, anger and relentless nature of kidney disease (always there) Weakness/Fatigue/Insomnia Weight gain/bloating None very difficult Figure.: Side effects that participants found difficult to cope with (% of all participants) Chronic Kidney Disease 0 Australian PEEK Study

10 Changes in medication Participants were asked whether they had ever needed to change medications. The main changes in medication noted were in relation to cardiovascular therapies, particularly blood pressure medications (n=;.%). There were participants (.%) that described a single change in medication for across a range of conditions and (.%) that had not had a change in medication. There were also seven participants (.00%) that described multiple changes in medications. The following quotes are in relation to changes in cardiovascular medications: Yes they are good at explaining... Okay. So the blood pressure medication has been increased in the past month or so. That seems to be has improved... My blood pressure has come down so that's seems to have helped it. That's the only thing I've noticed, that the doctors commented on. [Participant ] Table.: Changes in medication Section Yes. I think the Coversyl changed from... dosage just changed slightly, that was all. The blood pressure was dropping a little bit too much. I was getting a bit, sort of light headed just change the dosage a bit. NAME, the nephrologist, and the doctors sort of worked together on those things and NAME said you're on the best thing for it. [Participant ] Yeah, the doctor tried me on... I can't remember the name of it. It was another blood pressure med that diabetics use, so I tried that.and then I went back to him and said I don't want to take anything anymore, so... Yeah, but he swapped that over for me He always lets me know what we are up to. [Participant ] There was one variation in relation to sub-groups. Participants with stage disease reported changes in medication in relation to cardiovascular therapies less frequently than the general cohort (.00% compared to.% in the general cohort). Changes in medication (n=) by stage of disease Stage / n= Stage n=0 Stage / n= n=0 Participant had a change in medication (Cardiovascular medications/blood pressure).% Participant had a change in medication (Non specific/other) 0.% Participant had not had a change in medication.0% Participant had a change in medication (Many).% Participant had a change in medication (Change dose).%.00% 0.00% 0.00%.00%.00%.%.%.0%.%.%.%.%.%.00%.% Changes in medication (n=) comparison with comorbidities Participant had a change in medication (Cardiovascular medications/blood pressure) Anxiety n=.% Hyperkalaemia n=0.% Hypertension n=.% Sleep problems n= n=0.%.% Participant had a change in medication (Non specific/other).0%.%.0%.%.% Participant had not had a change in medication.%.%.0%.%.% Participant had a change in medication (Many).%.%.%.%.00% Participant had a change in medication (Change dose).%.00%.%.%.% Changes in medication (n=) comparison with location Participant had a change in medication (Cardiovascular medications/blood pressure) Regional/Rural n=.% Metropolitan n= 0.% n=0.% Participant had a change in medication (Non specific/other).% Participant had not had a change in medication. % Participant had a change in medication (Many).% Participant had a change in medication (Change dose).0% 0.%.%.0%.0%.%.%.00%.% Chronic Kidney Disease 0 Australian PEEK Study

11 Section Participant had a change in medication (Change dose) Participant had a change in medication (Many) Participant had not had a change in medication Participant had a change in medication (Non specific/other) Participant had a change in medication (Cardiovascular medications/blood pressure) Figure.: Changes in medication (% of all participants) As a follow-up question, participants were asked whether their doctor had provided a clear explanation for the reason for any changes in medication. The majority of participants (n=;.%) described changes in medication being explained and being satisfied with the explanation: Yeah, they always go through it, whether I listen is another story. [Participant ] Yes, yeah I did, my nephrologist I thought was really good and he did explain things and didn't treat me like an idiot, but it was complex getting it all right, but I sort of understood why all the changes. [Participant ] Yes, absolutely. It was normally just because of the high blood levels of something or other. And or lower blood levels needed to be adjusted. [Participant ] Yep. Yep, I've been very well informed about all that, a whole different regime, and that's still... I'm still seeing him, and I'm still doing weekly blood tests and seeing the nephrologist every fortnight, and we're still changing the mix of medications, just to try and get everything stabilised, and yes, no, I was informed, I think very well, why things are being changed, and what they're doing. [Participant ] There were also eight participants (.%) that described a change in medication being made at their request, often after conducting research of their own: No. I suggested it to him because I was having quite a stressful time with other things going on. His staff... I was taking my blood pressure and noticed it was going up. I figured the best thing to do was actually try to get it down and try not to damage my kidneys any further. [Participant ] It was driven by me, I would just take to telling her at the next appointment after two weeks, I had to stop taking the last one because I couldn't tolerate it. And the she'd say, "Oh, alright. Well, let's try this class of blood pressure medication. It's a different class than the other one, it operates a bit differently and maybe you'll be able to tolerate this one." So then we'd trial that one. At that point my appointments were three monthly. So it would be every three months I would be trying a new one. When I saw her. [Participant ] No, because I'm the one doing the research. I'm in the one that's in control of it. He might have made a suggestion, and I have to agree to it or not. [Participant 0] Chronic Kidney Disease 0 Australian PEEK Study

12 Section Table.: Explanations for changes in medication. Explanation of changes in medication (n=) by stage of disease Stage / n= Participant describes change in medication being explained/satisfied with explanation.% Participant describes change in medication not being explained/participant describes change in medication due to their request.0% Stage n=0.00%.00% Stage / n=.%.% n=0.%.% Explanation of changes in medication (n=) comparison with comorbidities Anxiety n= Hyperkalaemia n=0 Hypertension n= Sleep problems n= n=0 Participant describes change in medication being explained/satisfied with explanation Participant describes change in medication not being explained/participant describes change in medication due to their request.%.% 0.00%.%.0%.%.%.%.%.% Explanation of changes in medication (n=) comparison with location Participant describes change in medication being explained/satisfied with explanation Participant describes change in medication not being explained/participant describes change in medication due to their request Regional/Rural n=.%.% Metropolitan n=.%.% n=0.%.% Adherence to medications Participants were asked how long they stick with a therapy before they think it might not be working or give up on it. participants (.%) stated that they stick with medications as long as it is prescribed, often noting their trust in their treating clinician: Well the medication I just stick to because it's all prescribed by the Doctor. So that one I don't miss out, I don't skimp I just do it daily. [Participant ] Yeah. That's not a decision I would make on my own if it's to do with my treatment. I'm not just gonna give up on something without getting professional opinion from Yeah, from my renal team. There's no way I would just stop taking something just because I think it's not working. [Participant ] Look, I would probably... I'm the sort of person, I guess, I would probably keep taking until I was told not to. Yeah. Very obedient. [Participant ] There were ten participants (.%) that stated they adhere to medications as long as they feel they are working, and some participants relied on their regular check-ups and blood tests to determine this: Well, I'd follow... I just did what I was told, very compliant. It's all in response... they are basically aiming for biochemical markers that they're trying hit, so we had targets that they were trying to maintain, and I'd get the results of all my blood tests, and a lot of this stuff I was monitoring myself. [Participant ] Probably when I had the prints it wasn't working. So say a blood test or something like that. I don't know. [Participant ] I guess for me, it would be a case of seeing the results from tests if it's not working and obviously also from my queues from my nephrologist that is if it's not working then yes, we definitely want to try something else. [Participant ] An additional ten participants (.%) said that they maintain the therapy for two to three months to see if it is working (there were no participants with hyperkalaemia that noted this) and a further ten participants (.%) noted that they use the treatment as long as tolerated, without detriment to their health otherwise: Well, if I don't think it's working properly, if it's... It's hard to say I suppose. I don't know. It depends how long it takes to find out if it works or not, I guess. I don't know. It's a hard one to answer, but mostly as long as I can tolerate it it's fine. [Participant ] I've just stuck with everything that I've had to do. But I tend, I tend, if I'm told to do something, I'd probably go longer with what's anticipated in a couple of things in my lifetime... If this is an opportunity, it might make a difference. We'll just push through and see whether we can get well. [Participant ] I wouldn't stop things because I didn't feel like it was working, because I know things can work when you don't feel it working. It would mainly... Yeah, I would never stop because of that. Mainly, just if it made me physically feel not very well for an extended period of time. Yeah. [Participant ] Chronic Kidney Disease 0 Australian PEEK Study

13 Section Table.: How long patients stick to a therapy How long patients stick with a new therapy (n=) by stage of disease Stage / n= Stage n=0 Stage / n= n=0 As long as prescribed.0% 0.00%.0.% As long as/if its working and there is a benefit (e.g. test results).%.00%.%.% - months.%.00%.%.% As long as tolerated 0.%.00%.%.% - weeks.%.00%.%.% How long patients stick with a new therapy (n=) comparison with comorbidities Anxiety n= Hyperkalaemia n=0 Hypertension n= Sleep problems n= n=0 As long as prescribed.% 0.00%.0%.%.% As long as/if its working and there is a benefit (e.g. test results).% 0.00%.0%.%.% - months.% %.%.%.% As long as tolerated.%.%.%.%.% - weeks.%.%.%.%.% How long patients stick with a new therapy (n=) comparison with location Regional/Rural n= Metropolitan n= n=0 As long as prescribed.% As long as/if its working and there is a benefit (e.g. test results).% - months.% As long as tolerated.% - weeks.%.0%.%.0%.%.%.%.%.%.%.% - weeks As long as tolerated - months As long as/if its working and there is a benefit (e.g. test results) As long as prescribed 0 0 Figure.: How long patients stick to a therapy (% of all participants) Chronic Kidney Disease 0 Australian PEEK Study

14 There were a number of sub-group variations. Regional/rural participants reported adhering to medications for - months (.% compared to.0% for metropolitan participants) or as long as tolerated more frequently than metropolitan participants (.% compared to.% for metropolitan participants). There were also no participants with hyperkalaemia that reported adhering to medications for - months. What needs to change to feel like a treatment is working Participants were asked what needed to change for them to feel as though a treatment is working. The most common response was the need to see improvements in clinical tests, particularly blood tests (n=;.%): I've always had medical things that blood test results can kind of tell you where you're sitting so if I thought that my blood had increased in ways that it needed to, or decreased in ways that it needed to, I probably would have stuck to things, I'm a bit of a... bound by that. [Participant ] Table.: What needs to change to feel like a treatment is working Section If the treatment was prescribed regarding my blood test, if they looked at my blood test and noticed something, I'd want to see the change in my blood test. [Participant ] Well, I suppose for me to feel well. And if I'm getting lab results back showing that my kidney function has improved, or at least stayed the same. [Participant ] The other key theme was that participants generally needed to feel better and be able to do everyday tasks (n=0;.%). Obviously feel better, and be able to at least do some of my normal life duties. [Participant ] Just overall kind of quality of life and general wellbeing. I just want to feel like I can do things, I can get on with life without feeling lethargic or tired or in pain. So, if I feel there's a difference then I know that it's working. If I'm not feeling anything or if I'm feeling worse, it's not. [Participant ] Probably just overall feelings, yeah, wellness and stuff like that. General well-being. [Participant 0] What needs to change for patients to feel like treatment is working (n=) by stage of disease Stage / n= Stage n=0 Stage / n= n=0 Participants describes seeing the result of clinical tests.0% Participant describes needing to feel better generally and having energy to do everyday tasks.00%.00%.00%.0% /%.% 0.% What needs to change for patients to feel like treatment is working (n=) comparison with comorbidities Anxiety n= Hyperkalaemia n=0 Hypertension n= Sleep problems n= n=0 Participants describes seeing the result of clinical tests /% 0.00%.%.%.% Participant describes needing to feel better generally and having energy to do everyday tasks /%.%.%.% 0.% What needs to change for patients to feel like treatment is working (n=) comparison with location Regional/Rural n= Participants describes seeing the result of clinical tests 0.% Participant describes needing to feel better generally and having energy to do everyday tasks.% Metropolitan n=.%.% n=0.% 0.% Chronic Kidney Disease 0 Australian PEEK Study

15 Section Use of complementary therapies Participants were asked whether they had used any complementary therapies. Where complementary therapies were used, these were primarily vitamins and supplements (n=;.%)and massage (including physiotherapy) (n=;.%). Almost half of the participants (n=; %) stated that they did not use complementary therapies, with many noting that they would not do so without the permission of their treating clinician: No, because... if you're thinking about alternative medicines, you have to check all that out with a doctor because whatever you take... you have to be careful with the kidneys. [Participant ] I don't do that. I don't do any of that. I don't take any other dietary things, or... what do you call them? Alternative therapies. I don't do any of that, because I know that some of those sort of things can have adverse effects on the medications I'm actually on. Anything like that that I'm thinking about doing, I check with the doctor first. Yeah, don't do it. [Participant ] I don't. I don't do anything like that because I find it difficult, like with concerns about the complimentary medicine, then going back to talk to your specialist to make sure it's not going to effect your mainstream medicine, so to be honest I've avoided it because of that. I don't live close to my specialist. I see them every three months and it's not just like I can just pick up the phone and go. So regular medicine worked, so I'll put my faith in that at this point. [Participant ] Table.: Use of complementary therapies Use of complementary therapies (n=) by stage of disease Stage / n= Stage n=0 Stage / n= n=0 Participant describes not using complementary therapies.% Participant describes using vitamins/supplements.% Participant describes massage/physiotherapy.% Participant describes diet/lifestyle changes % Participant describes taking up exercise % 0.00% 0.00% 0.00% 0.00%.00%.%.%.%.%.%.%.%.%.00%.% Use of complementary therapies (n=) comparison with comorbidities Anxiety n= Hyperkalaemia n=0 Hypertension n= Sleep problems n= n=0 Participant describes not using complementary therapies.%.% 0.%.%.% Participant describes using vitamins/supplements.%.00%.%.%.% Participant describes massage/physiotherapy.%.00%.%.%.% Participant describes diet/lifestyle changes.%.00%.%.%.00% Participant describes taking up exercise.%.%.%.%.% Use of complementary therapies (n=) comparison with location Regional/Rural n= Participant describes not using complementary therapies.% Participant describes using vitamins/supplements.% Participant describes massage/physiotherapy.% Participant describes diet/lifestyle changes.% Participant describes taking up exercise.% Metropolitan n=.%.0%.%.%.% n=0.%.%.%.00%.% Chronic Kidney Disease 0 Australian PEEK Study

16 Section Participant describes not using complementary therapies Participant describes using vitamins/supplements Participant describes massage/physiotherapy Participant describes diet/lifestyle changes Participant describes taking up exercise Figure.: Use of complementary therapies (% of all participants) There were a number of sub-group variations. Participants with stage disease reported not using complementary therapies less frequently than the general cohort (0.00% compared to.% in the general cohort). They also described accessing massage or physiotherapy more frequently (0.00% compared to.% in the general cohort), while participants with stage / disease reported this less frequently (.% compared to.% in the general cohort). Participants with stage disease also reported diet and lifestyle changes more frequently than the general cohort (0.00% compared to 0.00% in the general cohort). Service provision and affordability Details about the healthcare system were participants were treated for CKD and financial complications from treatment are listed in Table.. The majority of participants were treated for CKD in the public healthcare system (n=, 0.00%), as a public patient (n=,.%), in the public hospital system (n=,.%) and had health insurance (n=,.%). The majority of patients never had to cancel healthcare appointments (n=, 0.00%), and they were never unable to afford essential prescriptions (n=,.%). However, over a third of participants (n=,.%) sometimes or often were unable to pay for basic necessities such as housing, food and electricity. Other costs to participants include the need for a carer (n=,.%) and changes in employment status resulting in lost income (n=,.%). Chronic Kidney Disease 0 Australian PEEK Study

17 Table.: Service provision and affordability Private health insurance N= % Yes. No. Treated as public or private patient N=0 % Equally public and private. Private. Public. Primary hospital system treated in N=0 % Both public and private. Private. Public 0.00 Had to delay or cancel healthcare appointments dues to N=0 % affordability Never 0.00 Rarely. Sometimes. Often. Unable to fill prescription due to cost N=0 % Never. Rarely. Sometimes.00 Often. Unable to pay for basic needs as a result of CKD diagnosis % Never. Rarely. Sometimes 0.00 Often. Had to pay for additional carers due to CKD N= % Yes. No. Section Change in employment due to CKD N=0 % I have had to quit my job. I have reduced the number of hours I work. I have taken leave with pay. I have taken leave without pay. I was retired or did not have a job when diagnosed. My work status has not changed 0.00 I have accessed my super.00 Chronic Kidney Disease 0 Australian PEEK Study

18 Change in carer job status N= % My carer had to quit their job. My carer has reduced the number of hours they work. My carer has taken leave with pay. My carer has taken leave without pay. My carer was retired or did not have a job when diagnosed. My carers work status has not changed. My carer has accessed their super Out of pocket expenses burden Extremely significant. Moderately significant. Somewhat significant 0. Slightly significant. Not significant at all. Section Chronic Kidney Disease 0 Australian PEEK Study

Section 5 Treatment and health service provision

Section 5 Treatment and health service provision Section 5 Treatment and health service provision Section 4: Experience of treatment Summary Treatments experienced The most commonly treatments reported were beta blockers (n=37; 74.%), followed by diuretics

More information

Section 4 Decision-making

Section 4 Decision-making Decision-making : Decision-making Summary Conversations about treatments Participants were asked to describe the conversation that they had with the clinician about treatment at diagnosis. The most common

More information

Section 4 Decision-making

Section 4 Decision-making Decision-making : Experience of health professional communication Conversations about s Participants were asked to describe the conversations they have had about mitochondrial disease options. The most

More information

This work has been submitted to NECTAR, the Northampton Electronic Collection of Theses and Research.

This work has been submitted to NECTAR, the Northampton Electronic Collection of Theses and Research. This work has been submitted to NECTAR, the Northampton Electronic Collection of Theses and Research. Conference or Workshop Item Title: Incentivised smoking cessation intervention with pregnant women:

More information

Hereditary Cancer Syndromes and the Obstetrician/Gynecologist

Hereditary Cancer Syndromes and the Obstetrician/Gynecologist Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/hereditary-cancer-syndromes-and-theobstetriciangynecologist/6990/

More information

Section 5 Treatment and health service provision

Section 5 Treatment and health service provision Treatment and health service provision : Experience of treatment Treatments experienced The most common treatments were surgery (n=94, 94.00%) and Radiation therapy (n=79, 79.00%). This was followed by

More information

PROSTATE CANCER SCREENING SHARED DECISION MAKING VIDEO

PROSTATE CANCER SCREENING SHARED DECISION MAKING VIDEO PROSTATE CANCER SCREENING SHARED DECISION MAKING VIDEO 1 00:00:00,067 --> 00:00:10,968 2 00:00:10,968 --> 00:00:12,701 So, you were given a decision aid sheet 3 00:00:12,701 --> 00:00:14,567 about prostate

More information

SECOND TRADITION SKIT

SECOND TRADITION SKIT SECOND TRADITION SKIT NARRATOR Welcome to the presentation of our skit on Al Anon's Second Tradition. I am Dolly Delegate and I'd like to introduce you to our cast. DOLLY DELEGATE AUDREY AUTHORITY BOSSY

More information

Script and Context. RN: Thanks, Ms. Deal. May I check your name bracelet? I just want to make sure the information is correct.

Script and Context. RN: Thanks, Ms. Deal. May I check your name bracelet? I just want to make sure the information is correct. Client appearance: Slouching in chair Hair unkempt Disheveled clothing Withdrawn Avoids eye contact initially Script and Context RN- adjunct clinical faculty SP- standardized patient (trained professional

More information

Statin Intolerance: Keys to Patient Counseling and Guidance

Statin Intolerance: Keys to Patient Counseling and Guidance Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/statin-intolerance-keys-to-patient-counseling-andguidance/7076/

More information

Recording Transcript Wendy Down Shift #9 Practice Time August 2018

Recording Transcript Wendy Down Shift #9 Practice Time August 2018 Recording Transcript Wendy Down Shift #9 Practice Time August 2018 Hi there. This is Wendy Down and this recording is Shift #9 in our 6 month coaching program. [Excuse that I referred to this in the recording

More information

VIDEO_ Sarah Hallberg - Interview (San Diego 2017)

VIDEO_ Sarah Hallberg - Interview (San Diego 2017) VIDEO_ Sarah Hallberg - Interview (San Diego 2017) Dr. Andreas Eenfeldt: If you are a doctor and you want to help your patients with type 2 diabetes to reverse their disease, how do you do it? You can

More information

The symptom recognition and help- seeking experiences of men in Australia with testicular cancer: A qualitative study

The symptom recognition and help- seeking experiences of men in Australia with testicular cancer: A qualitative study The symptom recognition and help- seeking experiences of men in Australia with testicular cancer: A qualitative study Stephen Carbone,, Susan Burney, Fiona Newton & Gordon A. Walker Monash University gordon.walker@med.monash.edu.au

More information

Diabetes Remission with Weight Loss - Frankly Speaking EP 49

Diabetes Remission with Weight Loss - Frankly Speaking EP 49 Diabetes Remission with Weight Loss - Frankly Speaking EP 49 Transcript Details This is a transcript of an episode from the podcast series Frankly Speaking accessible at Pri- Med.com. Additional media

More information

A Critical View of JUPITER

A Critical View of JUPITER Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/a-critical-view-of-jupiter/4124/

More information

MITOCW ocw f99-lec20_300k

MITOCW ocw f99-lec20_300k MITOCW ocw-18.06-f99-lec20_300k OK, this is lecture twenty. And this is the final lecture on determinants. And it's about the applications. So we worked hard in the last two lectures to get a formula for

More information

Problem Situation Form for Parents

Problem Situation Form for Parents Problem Situation Form for Parents Please complete a form for each situation you notice causes your child social anxiety. 1. WHAT WAS THE SITUATION? Please describe what happened. Provide enough information

More information

Why Are So Many Clinicians Choosing to Practice Functional Medicine?

Why Are So Many Clinicians Choosing to Practice Functional Medicine? Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/integrative-and-functional-medicine-in-practice/why-are-so-manyclinicians-choosing-practice-functional-medicine/8424/

More information

#032: HOW TO SAY YOU'RE SICK IN ENGLISH

#032: HOW TO SAY YOU'RE SICK IN ENGLISH #032: HOW TO SAY YOU'RE SICK IN ENGLISH Hi, everyone! I'm Georgiana, founder of SpeakEnglishPodcast.com. My mission is to help YOU to speak English fluently and confidently. In today's episode: I'll talk

More information

Sandi Mitchell. PhD Candidate The University of Sydney

Sandi Mitchell. PhD Candidate The University of Sydney Sandi Mitchell PhD Candidate The University of Sydney An estimated 242,500 (of 35.8 million) Canadians are infected with hepatitis C ~ 21% are undiagnosed (Public Health Agency of Canada, 2011) The majority

More information

Please Understand Me, Managing ADHD within a Marriage, this is Stay Happily Married episode number 222.

Please Understand Me, Managing ADHD within a Marriage, this is Stay Happily Married episode number 222. Announcer: Please Understand Me, Managing ADHD within a Marriage, this is Stay Happily Married episode number 222. Welcome to Stay Happily Married, your source for weekly updates on the latest tips and

More information

"PCOS Weight Loss and Exercise...

PCOS Weight Loss and Exercise... "PCOS Weight Loss and Exercise... By Dr. Beverly Yates Dr. of Naturopathic Medicine, PCOS Weight Loss Expert & Best Selling Author Table of Contents Introduction... 2 If You Are Dieting Do You Need To

More information

Using New Guidelines to Improve Best Practices in Obesity Management

Using New Guidelines to Improve Best Practices in Obesity Management Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

Can Angioplasty Improve Quality of Life for CAD Patients?

Can Angioplasty Improve Quality of Life for CAD Patients? Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/can-angioplasty-improve-quality-of-life-for-cadpatients/4000/

More information

The Sun is Setting for Sulfonylureas - Frankly Speaking EP 40

The Sun is Setting for Sulfonylureas - Frankly Speaking EP 40 The Sun is Setting for Sulfonylureas - Frankly Speaking EP 40 Transcript Details This is a transcript of an episode from the podcast series Frankly Speaking accessible at Pri- Med.com. Additional media

More information

The Current Research on Stretching and Flexibility is Flawed!

The Current Research on Stretching and Flexibility is Flawed! Transcript from: https://www.youtube.com/watch?v=qz0ot7tbbg0 Original Article: http://stretchcoach.com/articles/proper-stretching/ The Current Research on Stretching and Flexibility is Flawed! Hi. I'm

More information

Is modern life making us tired?

Is modern life making us tired? ENGLISH CONVERSATION WEDNESDAY 22ND AND THURSDAY 23RD JUNE 2016 18HOO Topic : Is modern life making us tired? From artificial lights, to late night TV, and now the ever-present glow of our smartphones,

More information

You re listening to an audio module from BMJ Learning. Hallo. I'm Anna Sayburn, Senior Editor with the BMJ Group s Consumer Health Team.

You re listening to an audio module from BMJ Learning. Hallo. I'm Anna Sayburn, Senior Editor with the BMJ Group s Consumer Health Team. Transcript of learning module Shared decision making (Dur: 26' 13") Contributors: Anna Sayburn and Alf Collins Available online at: http://learning.bmj.com/ V/O: You re listening to an audio module from

More information

How to Foster Post-Traumatic Growth

How to Foster Post-Traumatic Growth How to Foster Post-Traumatic Growth Module 9 - Transcript - pg. 1 How to Foster Post-Traumatic Growth Are Some Clients Predisposed for Post-Traumatic Growth? with Christine Padesky, PhD; Ron Siegel, PsyD;

More information

Adult Asthma My Days of Living in Tension with Asthma are Over!

Adult Asthma My Days of Living in Tension with Asthma are Over! Published on: 9 Jul 2014 Adult Asthma My Days of Living in Tension with Asthma are Over! Introduction This is a recent picture, taken when we went on a family picnic. We climbed up this big hill and I

More information

MS Learn Online Feature Presentation MS and Your Emotions, part two Deborah Miller, PhD. Tracey>> Welcome to MS Learn Online, I m Tracey Kimball.

MS Learn Online Feature Presentation MS and Your Emotions, part two Deborah Miller, PhD. Tracey>> Welcome to MS Learn Online, I m Tracey Kimball. Page 1 MS Learn Online Feature Presentation MS and Your Emotions, part two Deborah Miller, PhD Tracey>> Welcome to MS Learn Online, I m Tracey Kimball. Tom>> and I m Tom Kimball. In the first installment

More information

The Parent's Perspectives on Autism Spectrum Disorder

The Parent's Perspectives on Autism Spectrum Disorder Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/autism-spectrum/the-parents-perspectives-on-autism-spectrumdisorder/6809/

More information

How to Work with the Patterns That Sustain Depression

How to Work with the Patterns That Sustain Depression How to Work with the Patterns That Sustain Depression Module 5.2 - Transcript - pg. 1 How to Work with the Patterns That Sustain Depression How the Grieving Mind Fights Depression with Marsha Linehan,

More information

Summary Report. (Completion rate: 100.0%)

Summary Report. (Completion rate: 100.0%) Summary Report (Completion rate: 100.0%) I have been diagnosed with (check as many as apply) Chronic fatigue syndrome (ME/CFS) 83% 67 Fibromyalgia 54% 44 Irritable Bowel Syndrome 30% 24 Migraine 16% 13

More information

Why Tobacco Cessation?

Why Tobacco Cessation? Tobacco Cessation in Community Settings Introduction Hello and welcome to the Learning and Action Network event, Reaching Those in Need of Tobacco Cessation in Community Settings: Research, Recommendations

More information

Journey to Recovery: A Breast Cancer Podcast Series Episode 1, Part 1: A Breast Cancer Diagnosis

Journey to Recovery: A Breast Cancer Podcast Series Episode 1, Part 1: A Breast Cancer Diagnosis Journey to Recovery: A Breast Cancer Podcast Series Episode 1, Part 1: A Breast Cancer Diagnosis Doreen: When I was diagnosed with breast cancer, I felt shocked --extremely shocked -- and I felt like I

More information

11 - Blood Tests (Completed 05/29/18) Transcript by Rev.com. Page 1 of 5

11 - Blood Tests (Completed 05/29/18) Transcript by Rev.com. Page 1 of 5 Megan: Hey everyone, I'm Megan Ramos, and I'm here today to answer your questions. Today's question involves lab tests, and what blood tests you should ask your doctor for. You can find a list of recommended

More information

Increasing plasma donation frequency: Insights from current donors

Increasing plasma donation frequency: Insights from current donors Increasing plasma donation frequency: Insights from current donors Dr Rachel Thorpe Research and Development, Australian Red Cross Blood Service Background Retained plasmapheresis donors are critical to

More information

Steve Wood Control Blood Pressure Without Drugs

Steve Wood Control Blood Pressure Without Drugs Steve Wood Control Blood Pressure Without Drugs The following is taken from The Future of Health Now interview conducted by Ann Wixon with Steve Wood, co-founder of Cardiogrip Corporation. We have compiled

More information

Section 4 - Dealing with Anxious Thinking

Section 4 - Dealing with Anxious Thinking Section 4 - Dealing with Anxious Thinking How do we challenge our unhelpful thoughts? Anxiety may decrease if we closely examine how realistic and true our unhelpful/negative thoughts are. We may find

More information

Roles of Non-HDL Cholesterol in Risk Assessment and Treatment

Roles of Non-HDL Cholesterol in Risk Assessment and Treatment Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/roles-of-non-hdl-cholesterol-in-risk-assessment-andtreatment/7066/

More information

PATIENT SURVEY FOR ADMINISTRATIVE USE ONLY. TO BE COMPLETED BY STUDY COORDINATOR.

PATIENT SURVEY FOR ADMINISTRATIVE USE ONLY. TO BE COMPLETED BY STUDY COORDINATOR. PATIENT SURVEY FOR ADMINISTRATIVE USE ONLY. TO BE COMPLETED BY STUDY COORDINATOR. DATE OF VISIT: / / PATIENT ID: REGULAR PROVIDER: SITE OF VISIT: Cleveland Houston Manhattan Pittsburgh Thank you for agreeing

More information

Your Kidney Health. Your Choices. Chronic Kidney Disease

Your Kidney Health. Your Choices. Chronic Kidney Disease Your Kidney Health Your Choices Your doctor may have told you that you have chronic kidney disease (CKD or advanced kidney disease; or, you may be in kidney failure, and may have to make a decision about

More information

How to Foster Post-Traumatic Growth

How to Foster Post-Traumatic Growth How to Foster Post-Traumatic Growth Bonus 3, Part 2 - Transcript - pg. 1 How to Foster Post-Traumatic Growth How to Help Clients Complete the Journey From Trauma to Post-Traumatic Growth Part 2: 3 Core

More information

How to Foster Post-Traumatic Growth

How to Foster Post-Traumatic Growth How to Foster Post-Traumatic Growth Module 3 - Transcript - pg. 1 How to Foster Post-Traumatic Growth The Critical Role of Connection in Post-Traumatic Growth with Sue Johnson, EdD; Kelly McGonigal, PhD;

More information

After Soft Tissue Sarcoma Treatment

After Soft Tissue Sarcoma Treatment After Soft Tissue Sarcoma Treatment Living as a Cancer Survivor For many people, cancer treatment often raises questions about next steps as a survivor. What Happens After Treatment for Soft Tissue Sarcomas?

More information

How to Talk to Your Doctor About Psoriatic Arthritis

How to Talk to Your Doctor About Psoriatic Arthritis How to Talk to Your Doctor About Psoriatic Arthritis Preparing for your Doctor s Appointment Psoriatic arthritis is a type of arthritis that often occurs with psoriasis of the skin, a condition that features

More information

Cognitive Challenges After Hormone Therapy August 26, 2009 Webcast Monique Cherrier, Ph.D. Celestia Higano, M.D. Introduction

Cognitive Challenges After Hormone Therapy August 26, 2009 Webcast Monique Cherrier, Ph.D. Celestia Higano, M.D. Introduction Cognitive Challenges After Hormone Therapy August 26, 2009 Webcast Monique Cherrier, Ph.D. Celestia Higano, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of

More information

Welcome to Progress in Community Health Partnerships latest episode our Beyond the Manuscript podcast. In each

Welcome to Progress in Community Health Partnerships latest episode our Beyond the Manuscript podcast. In each Beyond the Manuscript 91 Podcast Interview Transcript Erin Kobetz, Joan Bloom, Irma Robbins, Kim Engelman Welcome to Progress in Community Health Partnerships latest episode our Beyond the Manuscript podcast.

More information

Michael Stone Week Four, Finding Stability in Times of Turbulence November 21, 2016 Healing from Trauma

Michael Stone Week Four, Finding Stability in Times of Turbulence November 21, 2016 Healing from Trauma Welcome to week four. My name is Michael Stone, and today we're going to continue exploring the theme of finding stability in times of turbulence. Last week we looked at bringing mindfulness practice to

More information

Courtesy of RosenfeldInjuryLawyers.com (888)

Courtesy of RosenfeldInjuryLawyers.com (888) CROSS-EXAMINATION BY MR. BERGER: Q DR. WATFORD, WE HAVE MET TWICE BEFORE. DO YOU RECALL THAT? Q ONCE IN YOUR IN DECEMBER, AND YOU WERE KIND ENOUGH TO MEET WITH US? Q ONCE IN JANUARY WHEN WE BROUGHT YOU

More information

Fostering a "Back to Basics" Model in Type 2 Diabetes Care

Fostering a Back to Basics Model in Type 2 Diabetes Care Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/diabetes-discourse/fostering-a-back-to-basics-model-for-type-2-

More information

Stories of depression

Stories of depression Stories of depression Does this sound like you? D E P A R T M E N T O F H E A L T H A N D H U M A N S E R V I C E S P U B L I C H E A L T H S E R V I C E N A T I O N A L I N S T I T U T E S O F H E A L

More information

Carotid Ultrasound Scans for Assessing Cardiovascular Risk

Carotid Ultrasound Scans for Assessing Cardiovascular Risk Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/carotid-ultrasound-scans-for-assessing-cardiovascularrisk/4004/

More information

Jim: Welcome to "Get Fit with Ted," where we're going to take the workout out of the gym and into your home.

Jim: Welcome to Get Fit with Ted, where we're going to take the workout out of the gym and into your home. JIM Is a "gym guy TED Not a "gym guy Jim: Hi, I'm Jim. Ted: I'm Ted. Title: Get Fit with Ted The "ungym Workout Jim: Welcome to "Get Fit with Ted," where we're going to take the workout out of the gym

More information

Beyond The Data: Promoting Well-being in Older Adults

Beyond The Data: Promoting Well-being in Older Adults Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/grand-rounds-nation/beyond-data-promoting-well-being-olderadults/9844/

More information

We admitted that we were powerless over alcohol that our lives had become unmanageable.

We admitted that we were powerless over alcohol that our lives had become unmanageable. Step One We admitted that we were powerless over alcohol that our lives had become unmanageable. Alcoholics Anonymous (AA) (2001, p. 59) Before beginning this exercise, please read Step One in Twelve Steps

More information

Mark Hyman, M.D. Transcript

Mark Hyman, M.D. Transcript Mark Hyman, M.D. Transcript Mark Hyman, M.D.: I've been seeing chronically ill patients for 20 years, and there are certain patients who are resistant to getting better using functional medicine, and when

More information

Carol White Interview, May J: June C: Carol

Carol White Interview, May J: June C: Carol Carol White Interview, May 2015 J: June C: Carol Interview starts 15:25 J: Can you hear me ok? C: Yeah. J: Ok. My name is June Hussey and I'm pleased to meet you by phone. C: Pleased to meet you too. J:

More information

ANAEMIA MANAGEMENT: THE KDIGO RECOMMENDATIONS Patrick S. Parfrey, St. John s, Canada

ANAEMIA MANAGEMENT: THE KDIGO RECOMMENDATIONS Patrick S. Parfrey, St. John s, Canada ANAEMIA MANAGEMENT: THE KDIGO RECOMMENDATIONS Patrick S. Parfrey, St. John s, Canada Chair: Kai- Uwe Eckardt, Erlangen, Germany Pierre- Yves Martin, Geneva, Switzerland Prof. Patrick S. Parfrey Division

More information

We admitted that we were powerless over alcohol that our lives had become unmanageable. Alcoholics Anonymous (AA) (2001, p. 59)

We admitted that we were powerless over alcohol that our lives had become unmanageable. Alcoholics Anonymous (AA) (2001, p. 59) Step One 22 istockphoto.com/qingwa We admitted that we were powerless over alcohol that our lives had become unmanageable. Alcoholics Anonymous (AA) (2001, p. 59) Before beginning this exercise, please

More information

After Adrenal Cancer Treatment

After Adrenal Cancer Treatment After Adrenal Cancer Treatment Living as a Cancer Survivor For many people, cancer treatment often raises questions about next steps as a survivor. Lifestyle Changes After Treatment for Adrenal Cancer

More information

Helping Kidney Stones Pass: Use of Alpha Antagonists Frankly Speaking EP7

Helping Kidney Stones Pass: Use of Alpha Antagonists Frankly Speaking EP7 Helping Kidney Stones Pass: Use of Alpha Antagonists Frankly Speaking EP7 Transcript Details This is a transcript of an episode from the podcast series Frankly Speaking accessible at Pri- Med.com. Additional

More information

File No WORLD TRADE CENTER TASK FORCE INTERVIEW FIREFIGHTER MIKE ZECHEWYTZ. Interview Date: December 5, Transcribed by Nancy Francis

File No WORLD TRADE CENTER TASK FORCE INTERVIEW FIREFIGHTER MIKE ZECHEWYTZ. Interview Date: December 5, Transcribed by Nancy Francis File No. 9110242 WORLD TRADE CENTER TASK FORCE INTERVIEW FIREFIGHTER MIKE ZECHEWYTZ Interview Date: December 5, 2001 Transcribed by Nancy Francis 2 CHIEF LAKIOTES: Today is December 5th, 2001. The time

More information

How to Motivate Clients to Push Through Self-Imposed Boundaries

How to Motivate Clients to Push Through Self-Imposed Boundaries How to Help Clients Overcome Their Most Limiting Fears, Part 2 McGonigal, PhD - Transcript - pg. 1 How to Help Clients Overcome Their Most Limiting Fears, Part 2: Kelly McGonigal, PhD How to Motivate Clients

More information

Hello and welcome to Patient Power sponsored by Northwestern Memorial Hospital. I'm Andrew Schorr.

Hello and welcome to Patient Power sponsored by Northwestern Memorial Hospital. I'm Andrew Schorr. Brain Tumor Clinical Trials Webcast November 22, 2011 Sean Grimm, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of Northwestern Memorial Hospital, its medical

More information

Selected Proceedings of ALDAcon SORENSON IP RELAY Presenter: MICHAEL JORDAN

Selected Proceedings of ALDAcon SORENSON IP RELAY Presenter: MICHAEL JORDAN Selected Proceedings of ALDAcon 2005 SORENSON IP RELAY Presenter: MICHAEL JORDAN MICHAEL JORDAN: Okay. I m excited to be here. I feel that the communication that Sorenson has and will continue to provide

More information

Marty: I had my physical in 2006, and my physician said that I had myelofibrosis and said I had three to five years to live.

Marty: I had my physical in 2006, and my physician said that I had myelofibrosis and said I had three to five years to live. Advances in the Treatment of Myeloproliferative Disorders Webcast April 28, 2009 Srdan Verstovsek, M.D., Ph.D. Marty Prager Please remember the opinions expressed on Patient Power are not necessarily the

More information

Oral Health and Dental Services report

Oral Health and Dental Services report Oral Health and Dental Services report The Hive and Healthwatch have been working in partnership to gain an insight from the learning disabled community about Oral Health and Dental Services. Their views

More information

National Institute on Drug Abuse (NIDA) What is Addiction?

National Institute on Drug Abuse (NIDA) What is Addiction? National Institute on Drug Abuse (NIDA) What is Addiction? https://www.drugabuse.gov 1 Table of Contents What is Addiction? Do You or a Loved One Have a Drug Abuse Problem? Signs of Drug Abuse and Addiction

More information

What family members have told us about having HIV at home

What family members have told us about having HIV at home Family Matters Changing Lives Chapter 6 P1 The great indoors the family living with HIV HIV has brought us closer together. The most important part of the day is around the kitchen table for dinner. We

More information

Unseen and unheard: women s experience of miscarriage many years after the event

Unseen and unheard: women s experience of miscarriage many years after the event Unseen and unheard: women s experience of miscarriage many years after the event The Forbidden in Counselling and Psychotherapy Keele Conference 2012 Lois de Cruz The wide mouth frog effect Aim Of my PhD

More information

Family Man. a prime example of change. My dads past was riddled with chaos and bad decisions. My dad

Family Man. a prime example of change. My dads past was riddled with chaos and bad decisions. My dad Norton 1 Elizabeth Norton Professor Watkins English 1A September 9, 2015 Family Man It is hard to believe that someone can turn their life around in an instance, but my father is a prime example of change.

More information

Spring Survey 2014 Report - ADULTS

Spring Survey 2014 Report - ADULTS RESPONDANTS Spring Survey 2014 Report - ADULTS Responses from the ADULTS section of our Spring Survey 2014 came from 108 (out of 668) participants who said they were born with a cleft and were over 18.

More information

Principles and language suggestions for talking with patients

Principles and language suggestions for talking with patients SAFER MANAGEMENT OF OPIOIDS FOR CHRONIC PAIN: Principles and language suggestions for talking with patients Use these principles and language suggestions when discussing opioid risks and safety monitoring

More information

Autoimmune disorders: An emerging risk factor for CV disease

Autoimmune disorders: An emerging risk factor for CV disease Autoimmune disorders: An emerging risk factor for CV disease DR. SHARON MULVAGH: Greetings. I'm Dr Sharon Mulvagh, professor of medicine and director of Mayo Clinic Women's Heart Clinic. During today's

More information

HIV PREVENTION WITH PRE-EXPOSURE PROPHYLAXIS: A PRIMER FOR PHARMACISTS. Speaker: Susan MK Lee, PharmD, BCPS, CDE

HIV PREVENTION WITH PRE-EXPOSURE PROPHYLAXIS: A PRIMER FOR PHARMACISTS. Speaker: Susan MK Lee, PharmD, BCPS, CDE Clinical Education Initiative Support@ceitraining.org HIV PREVENTION WITH PRE-EXPOSURE PROPHYLAXIS: A PRIMER FOR PHARMACISTS Speaker: Susan MK Lee, PharmD, BCPS, CDE 12/13/2016 HIV Prevention with Pre-Exposure

More information

One of the areas where it's certainly made it difference is with the transplantation of the liver. Dr. Roberts thinks so much for joining us.

One of the areas where it's certainly made it difference is with the transplantation of the liver. Dr. Roberts thinks so much for joining us. Benefits and Risks of Living Donor Liver Transplant Webcast May 28, 2008 John Roberts, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UCSF Medical Center,

More information

BroadcastMed The Relationship Between Sleep Apnea and Cardiovascular Disease

BroadcastMed The Relationship Between Sleep Apnea and Cardiovascular Disease BroadcastMed The Relationship Between Sleep Apnea and Cardiovascular Disease Howdy, I'm Jay Widmer, cardiology fellow here at Mayo Clinic, Rochester. During today's recording, we'll be discussing sleep

More information

HIV Housing Care Continuum Webinar 1 August 3, 2016

HIV Housing Care Continuum Webinar 1 August 3, 2016 Page 1 HIV Housing Care Continuum August 3, 2016 Rita Flegel: Hello and welcome. I'm Rita Flegel, the Director of HUD's Office of HIV/AIDS Housing. And presenting with me today is Amy Palilonis also from

More information

MALE LIBIDO- EBOOKLET

MALE LIBIDO- EBOOKLET MALE LIBIDO- EBOOKLET Hi there, Thank you for ordering this Native Remedies ebooklet! ebooklets are modified from consultations with real people and cover some of the most frequently dealt with problems

More information

Episode Flexibility & Mobility in Martial Arts whistlekickmartialartsradio.com

Episode Flexibility & Mobility in Martial Arts whistlekickmartialartsradio.com Jeremy Lesniak: Welcome to whistlekick martial arts radio episode 235. Today were gonna talk abouzt flexibility and mobility within the martial arts. I wanna thank you for tuning in. My name is Jeremy

More information

Dr. Michael Keating: My Hopes for the Future of CLL Treatment Recorded on December 8, 2014

Dr. Michael Keating: My Hopes for the Future of CLL Treatment Recorded on December 8, 2014 Patient Power Knowledge. Confidence. Hope. Dr. Michael Keating: My Hopes for the Future of CLL Treatment Recorded on December 8, 2014 Michael Keating, MB, BS Professor of Medicine, Department of Leukemia

More information

Coping with Depression

Coping with Depression Coping with Depression How can I help reduce healthcare associated infections? Infection control is important to the well-being of our patients and for that reason we have infection control procedures

More information

Next Level Practitioner

Next Level Practitioner Next Level Practitioner - Best Advice Week 88, Day 3 - Ed Tronick, PhD - Transcript - pg. 1 Next Level Practitioner Week 88: Treatment Specific Advice Day 3: How Advice Can Change Our Outlook on Our Therapeutic

More information

Benefits of Survivorship Treatment Care Plans Webcast May 13, 2009 Scott Baker, M.D., M.S. Donald Wilhelm. Introduction

Benefits of Survivorship Treatment Care Plans Webcast May 13, 2009 Scott Baker, M.D., M.S. Donald Wilhelm. Introduction Benefits of Survivorship Treatment Care Plans Webcast May 13, 2009 Scott Baker, M.D., M.S. Donald Wilhelm Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle

More information

I don t want to be here anymore. I m really worried about Clare. She s been acting different and something s not right

I don t want to be here anymore. I m really worried about Clare. She s been acting different and something s not right I just can t take what s happening at home anymore Clare 23 mins Instagram When your friend is thinking about suicide I don t want to be here anymore... I m really worried about Clare. She s been acting

More information

Needs-Motivated Behavior Interview

Needs-Motivated Behavior Interview Needs-Motivated Behavior Interview Dr. Michael O Connor interviewed by Rich Meese Rich Meese: Hello. My name is Rich Meese, and for the past twelve plus years I've had the privilege of working with a variety

More information

Letter to the teachers

Letter to the teachers Letter to the teachers Hello my name is Sasha Jacombs I m 12 years old and I have had Type 1 Diabetes since I was four years old. Some of the people reading this may not know what that is, so I had better

More information

Felden-WHAT? By Lawrence Wm. Goldfarb , All Rights Reserved

Felden-WHAT? By Lawrence Wm. Goldfarb , All Rights Reserved Felden-WHAT? By Lawrence Wm. Goldfarb 1993-94, All Rights Reserved It was about to happen; that moment, that dreaded moment. I was at my friend Marcello's birthday party, enjoying the Brazilian music when

More information

The Impact of Erectile Dysfunction on Partners of Men with ED

The Impact of Erectile Dysfunction on Partners of Men with ED The Impact of Erectile Dysfunction on Partners of Men with ED Nicholson, Robert T. ED Treatment Information Center December 15, 2018 Abstract A survey of 129 adult partners of men with erectile dysfunction

More information

The Wellbeing Course. Resource: Mental Skills. The Wellbeing Course was written by Professor Nick Titov and Dr Blake Dear

The Wellbeing Course. Resource: Mental Skills. The Wellbeing Course was written by Professor Nick Titov and Dr Blake Dear The Wellbeing Course Resource: Mental Skills The Wellbeing Course was written by Professor Nick Titov and Dr Blake Dear About Mental Skills This resource introduces three mental skills which people find

More information

Overseen by: Prof. Judy Freedman Fask, College of the Holy Cross

Overseen by: Prof. Judy Freedman Fask, College of the Holy Cross Interviewee:Dennise Scott Interviewer: Lauren Spadaro Interpretors: Rebecca Blusenheim, Bethany Bertrand, Northeastern University Date of Interview: May 8, 2007 Location: College of the Holy Cross Overseen

More information

Understanding Acute Kidney Injury and Its Impact

Understanding Acute Kidney Injury and Its Impact Understanding Acute Kidney Injury and Its Impact Recorded on: March 7, 2013 Chi-Yuan Hsu, M.D., M.S. Chief of the Division of Nephrology, UCSF Department of Medicine UCSF Medical Center Raymond Hsu, M.D.

More information

Our plan for giving better care to people with dementia Oxleas Dementia

Our plan for giving better care to people with dementia Oxleas Dementia Our plan for giving better care to people with dementia Oxleas Dementia 2013-2016 November 2013 1 Contents 1. What is our plan about? 2. Finding out if someone has dementia 3. Finding out the care and

More information

GENERAL INFORMATION PROFESSIONAL REFERRAL INFORMATION

GENERAL INFORMATION PROFESSIONAL REFERRAL INFORMATION SO THAT WE MAY BETTER SERVE YOU, PLEASE COMPLETE THE FOLLOWING FORM AND EITHER BRING THE COMPLETED FORM WITH YOU TO YOUR FIRST APPOINTEMNT OR SCAN IT AND EMAIL IT TO OFFICE, PRIOR TO YOUR APPOINTMENT LORRAINE@ANALIPSONMD.COM

More information

Melanie Hawkins 1*, Stephen D Gill 2, Roy Batterham 1,3, Gerald R Elsworth 1 and Richard H Osborne 1

Melanie Hawkins 1*, Stephen D Gill 2, Roy Batterham 1,3, Gerald R Elsworth 1 and Richard H Osborne 1 Hawkins et al. BMC Health Services Research (2017) 17:309 DOI 10.1186/s12913-017-2254-8 RESEARCH ARTICLE The Health Literacy Questionnaire (HLQ) at the patient-clinician interface: a qualitative study

More information

and MS: Mood Changes For those

and MS: Mood Changes For those MS Learn Online Featuree Presentation Mood Changes and MS: The Rolee of Healthy Grieving Featuring: Sarah Minden, MD; David Rintell, PhD; Rosalind Kalb, PhD Cathy: I hate the phrase of, "Well, you look

More information

Why Is Mommy Like She Is?

Why Is Mommy Like She Is? Why Is Mommy Like She Is? A Book For Kids About PTSD Deployment Edition Patience H. C. Mason Patience Press High Springs, Florida PP Patience Press 2010 by Patience Mason All rights reserved. No part of

More information